4 results
Primary Objective: Is the detection chance of the bladder influenced by the angle in which the ultrasound sensor is fixated? Secondary Objective Can the URIKA Bladder Monitor (UBM) be used to predict the point where the BladderScan reaches the…
To determine the safety and efficacy of Dimebon in patients with mild to moderate Huntington Disease
To determine the benefit of Dimebon as compared to placebo on the primary measure of cognition and memory, the Alzheimer*s Disease Assessment Scale * cognitive subscale (ADAS-cog); andTo determine the benefit of Dimebon as compared to placebo on the…
To evaluate the long-term safety and tolerability of Dimebon in AD patients who have successfully completed 26 weeks of blinded treatment in the CONNECTION Study (DIM14) (hereafter referred to as *CONNECTION*).